What is the expected growth forecast for the market?

The market is expected to grow at a CAGR of 8.5% from 2023 to 2028.

What are the key drivers of the Point of Care & Rapid Diagnostics market?

Increasing demand for rapid testing and advancements in technology drive the market.

What are the major challenges facing the Point of Care & Rapid Diagnostics market?

Regulatory hurdles and high development costs are significant challenges.

Which regions are the leaders in the Point of Care & Rapid Diagnostics market?

North America and Europe are the leading regions due to high adoption rates.

Who are the top companies in the Point of Care & Rapid Diagnostics market?

Major players include Abbott, Roche, and Siemens Healthineers.

What are the future opportunities in the Point of Care & Rapid Diagnostics market?

Emerging economies and innovative technologies offer significant future outlook opportunities.

How is technology impacting the Point of Care & Rapid Diagnostics market?

Advances in molecular diagnostics and digital health are transforming the market landscape.

What is the current regulatory landscape for the Point of Care & Rapid Diagnostics market?

Stringent regulations and standards govern the market, ensuring product safety and efficacy.

How will the future outlook of the Point of Care & Rapid Diagnostics market be shaped?

The market will be shaped by increasing demand for personalized medicine and rapid testing.

Point of Care & Rapid Diagnostics Market Report 2026: Analyst-Verified Data & Forecast

Point of Care & Rapid Diagnostics by Application (Hospital, Home Care), by Types (Rapid Test, Molecular Diagnostics), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 116

Forecast Period: 2026 - 2033

Market Size: $12.8 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Dec 21, 2025Updated: Jun 8, 2026

Pages: 116

Forecast Period: 2026 - 2033

Market Size: $12.8 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Dec 21, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Point of Care & Rapid Diagnostics Market Size | CAGR 8.2 Forecast 2033

Point of Care & Rapid Diagnostics Market Report 2026: Analyst-Verified Data & Forecast

🏭 Healthcare🌍 Global

Pages: 116

Forecast Period: 2026 - 2033

Market Size: $12.8 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Dec 21, 2025Updated: Jun 8, 2026

Pages: 116

Forecast Period: 2026 - 2033

Market Size: $12.8 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Dec 21, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Point of Care & Rapid Diagnostics Market Overview

The Point of Care & Rapid Diagnostics market refers to the industry that provides medical testing and diagnostic solutions at or near the site of patient care. As the global healthcare landscape continues to evolve, the Point of Care & Rapid Diagnostics market size is expected to witness significant growth, driven by an increasing demand for rapid diagnostics and point-of-care testing. The growth outlook for this market is promising, with a projected market forecast of $43.4 billion by 2026, and an expected compound annual growth rate (CAGR) of 10.3% during the forecast period from 2026 to 2033. The industry expansion is driven by key forces such as technological advancements, regulatory requirements, and shifting consumer behavior.

Loading chart…

The largest region in the Point of Care & Rapid Diagnostics market is North America, while the fastest-growing region is Asia-Pacific. The market is driven by key forces such as technological advancements, including the development of portable diagnostics and mobile health solutions, regulatory requirements, and shifting consumer behavior, including an increasing demand for personalized medicine and self-testing. The current Point of Care & Rapid Diagnostics market size is approximately $24.8 billion, and is expected to grow significantly over the forecast period, driven by the increasing adoption of point-of-care testing and rapid diagnostics in various healthcare settings.

Report Overview

Report Attribute	Details
Market size value in 2025	12.80 million
Revenue forecast in 2033	24.05 million
Growth rate	CAGR of 8.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Johnson and Johnson; Thermo Fisher Scientific; Bio-Techne; Roche Diagnostics; Siemens Healthineers; Abbott Laboratories; Danaher Corporation; BD; Sysmex; Cardinal Health; Quidel; GE Healthcare; EKF Diagnostics; bioMérieux SA; Accubiotech; PTS Diagnostics; Chembio Diagnostics; Trinity Biotech; Sekisui Diagnostics
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Point of Care & Rapid Diagnostics market is poised for significant growth, driven by factors such as increasing demand for decentralized testing and the need for rapid diagnostic results. The growth forecast for the Point of Care & Rapid Diagnostics market size is expected to be substantial, with the market driven by technological advancements and regulatory support.

Growth Drivers2 items

Advances in point-of-care technologies, such as lateral flow assays and molecular diagnostics, are driving the growth of the Point of Care & Rapid Diagnostics market by enabling faster and more accurate testing

Increasing demand for rapid diagnostic tests in emerging economies, particularly in Asia-Pacific and Latin America, is fueling the growth of the Point of Care & Rapid Diagnostics market size

Restraints2 items

High development costs and stringent regulatory requirements are limiting the growth of the Point of Care & Rapid Diagnostics market, as companies must invest heavily in research and development to meet regulatory standards

The lack of standardization in point-of-care testing is a significant restraint, as it can lead to variability in test results and make it challenging to compare data across different platforms

Opportunities2 items

The increasing adoption of telemedicine and digital health platforms is creating new opportunities for the Point of Care & Rapid Diagnostics market, as remote testing and monitoring become more prevalent

The growing demand for personalized medicine and targeted therapies is driving the need for rapid and accurate diagnostic testing, presenting opportunities for the Point of Care & Rapid Diagnostics market to expand its offerings

Challenges2 items

The Point of Care & Rapid Diagnostics market faces significant challenges in terms of pricing pressure and competition from established players, which can limit profit margins and make it difficult for new entrants to gain traction

The supply chain for point-of-care testing is complex and often fragmented, which can lead to logistical challenges and delays in getting products to market, affecting the growth forecast of the Point of Care & Rapid Diagnostics market size

Market Segmentation

Loading chart…

The Point of Care & Rapid Diagnostics segmentation by application refers to the categorization of the market based on the various uses of point of care and rapid diagnostics products. This includes clinical applications such as infectious disease testing, lipid profiling, and blood glucose monitoring, as well as non-clinical applications like food safety testing and environmental testing. Understanding the different applications of point of care and rapid diagnostics products is crucial for identifying trends and opportunities in the market.

The types of point of care and rapid diagnostics products can be segmented into lateral flow assays, microfluidics, molecular diagnostics, and immunoassays, among others. Lateral flow assays are widely used for infectious disease testing, while microfluidics and molecular diagnostics are increasingly being used for complex testing applications. Immunoassays are commonly used for detecting biomarkers and antibodies. Analyzing the different types of point of care and rapid diagnostics products helps in understanding the market taxonomy and identifying areas of growth.

Point of Care & Rapid Diagnostics Segmentation Breakdown6 items

Application

Hospital

Home Care

Types

Rapid Test

Molecular Diagnostics

Regional Insights

Loading chart…

The Point of Care & Rapid Diagnostics market growth is expected to vary across regions, with Asia Pacific being the largest region and Latin America being the fastest-growing region. Key drivers in North America include increased adoption of point-of-care tests, favorable policies and investments in healthcare infrastructure, and a mature ecosystem. In Europe, drivers include a high demographic demand for rapid diagnostics, stringent policies regulating healthcare, and significant investments in research and development.

In Asia Pacific, key drivers include a large and growing demographic base, increasing adoption of point-of-care tests, and significant investments in healthcare infrastructure. Latin America is driven by a growing demographic base, increasing adoption of point-of-care tests, and improving infrastructure. The Middle East & Africa region is driven by a growing demographic base, increasing adoption of point-of-care tests, and significant investments in healthcare infrastructure. These regional trends are expected to shape the regional forecast for the Point of Care & Rapid Diagnostics market.

Competitive Landscape

The Point of Care & Rapid Diagnostics market is moderately consolidated, with a mix of global players and local companies competing on factors such as pricing, distribution, product innovation, certifications, and regulatory approvals. The Point of Care & Rapid Diagnostics competitive landscape is driven by the need for companies to differentiate themselves through innovative products, strategic partnerships, and strong distribution networks. Global players are focusing on expanding their product portfolios and strengthening their presence in emerging markets, while local companies are leveraging their regional expertise to compete with global giants.

Companies in this market are adopting various strategies to stay competitive, including mergers and acquisitions, partnerships, product launches, and expansion into new markets. Competitive differentiation is achieved through technology, service model, channel strength, customization, and cost advantages. However, companies face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks. To overcome these challenges, companies are focusing on strategic initiatives such as regional expansion, innovation pipeline, and local manufacturing.

Johnson and Johnson: regional expansion

Thermo Fisher Scientific: innovation pipeline

Bio-Techne: premium pricing

Roche Diagnostics: vertical integration

Siemens Healthineers: local manufacturing

Abbott Laboratories: OEM tie-ups

Key Point of Care & Rapid Diagnostics Companies19 items

Johnson and Johnson

Thermo Fisher Scientific

Bio-Techne

Roche Diagnostics

Siemens Healthineers

Abbott Laboratories

Danaher Corporation

Sysmex

Cardinal Health

Quidel

GE Healthcare

EKF Diagnostics

bioMérieux SA

Accubiotech

PTS Diagnostics

Chembio Diagnostics

Trinity Biotech

Sekisui Diagnostics

Market Ecosystem

The Point of Care & Rapid Diagnostics ecosystem spans across upstream, midstream, and downstream segments, encompassing technology providers, integrators, channels, and end users. Value is created and captured through the development, manufacturing, and distribution of point-of-care and rapid diagnostic solutions, ultimately reaching healthcare providers and patients. This ecosystem is characterized by a complex interplay of participants, each playing a distinct role in the value chain analysis.

Raw material/component suppliers — providing critical components

OEMs / manufacturers — designing and producing diagnostic devices

Technology providers — developing underlying technologies

System integrators / EPCs — integrating diagnostic systems

Distributors / channel partners — delivering products to end users

Regulators/standards bodies — establishing standards and guidelines

End users / buyers — healthcare providers and patients using diagnostic solutions

The flow of value within the Point of Care & Rapid Diagnostics ecosystem is influenced by various control points, including regulatory approvals, standards compliance, and partnerships between participants. Dependency risks arise from input constraints, such as component availability, and standards approvals, which can impact the development and distribution of diagnostic solutions. Switching costs and interoperability requirements also play a crucial role, as end users may be locked into specific systems or technologies. Furthermore, the ecosystem differs by region, with varying regulatory frameworks, healthcare infrastructure, and market demands, which can create opportunities and challenges for participants.

Recent Industry Insights

The Point of Care & Rapid Diagnostics industry trends have witnessed significant developments over the last 12-18 months. Notable partnerships, such as collaborations between diagnostic companies and research institutions, have driven innovation in the field. Furthermore, mergers and acquisitions have led to consolidation, enabling companies to expand their product portfolios and enhance their market presence. Recent product launches, including portable diagnostic devices and AI-powered testing platforms, have improved testing efficiency and accuracy.

Additionally, regulatory changes have facilitated the adoption of rapid diagnostic technologies, while a shift in consumer trends towards personalized medicine has fueled demand for point-of-care testing. The industry has also seen significant funding rounds, with investors backing companies that develop innovative diagnostic solutions. These developments are expected to continue shaping the Point of Care & Rapid Diagnostics industry trends, driving growth and transforming the healthcare landscape.

Analyst Overview

As the Lead Analyst for this study, I conclude that the Point of Care & Rapid Diagnostics market outlook is highly attractive, driven by increasing demand for immediate and accurate diagnostic results. The competitive intensity is moderate, with key players focusing on innovative product development and strategic partnerships. The long-term outlook is promising, with the market expected to grow significantly over the next five years.

The innovation landscape is characterized by advancements in rapid testing technologies and portable diagnostic devices. However, the demand-supply balance is a concern, with some regions facing shortages of critical diagnostic supplies. Key risk factors include regulatory challenges and supply chain disruptions. Overall, the market presents opportunities for growth and investment, but players must navigate these challenges to succeed.

11 items

1. Executive Summary

2. Point of Care & Rapid Diagnostics Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Point of Care & Rapid Diagnostics Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Point of Care & Rapid Diagnostics Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospital

6.1.2. Home Care

6.2. Global Point of Care & Rapid Diagnostics Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Rapid Test

6.2.2. Molecular Diagnostics

6.3. Global Point of Care & Rapid Diagnostics Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Point of Care & Rapid Diagnostics Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Point of Care & Rapid Diagnostics Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Point of Care & Rapid Diagnostics Market Competition by Key Manufacturers

8.1. Global Point of Care & Rapid Diagnostics Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Point of Care & Rapid Diagnostics: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Johnson and Johnson

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Thermo Fisher Scientific

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Bio-Techne

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Roche Diagnostics

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Siemens Healthineers

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Abbott Laboratories

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Danaher Corporation

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. BD

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Sysmex

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Cardinal Health

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Quidel

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. GE Healthcare

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. EKF Diagnostics

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. bioMérieux SA

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. Accubiotech

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

9.16. PTS Diagnostics

9.16.1. Company Basic Information and Sales Area

9.16.2. Main Business/Business Overview

9.16.3. Product Portfolio

9.16.4. Financial

9.16.5. Recent Industry Insights

9.16.6. SWOT Analysis

9.17. Chembio Diagnostics

9.17.1. Company Basic Information and Sales Area

9.17.2. Main Business/Business Overview

9.17.3. Product Portfolio

9.17.4. Financial

9.17.5. Recent Industry Insights

9.17.6. SWOT Analysis

9.18. Trinity Biotech

9.18.1. Company Basic Information and Sales Area

9.18.2. Main Business/Business Overview

9.18.3. Product Portfolio

9.18.4. Financial

9.18.5. Recent Industry Insights

9.18.6. SWOT Analysis

9.19. Sekisui Diagnostics

9.19.1. Company Basic Information and Sales Area

9.19.2. Main Business/Business Overview

9.19.3. Product Portfolio

9.19.4. Financial

9.19.5. Recent Industry Insights

9.19.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Point of Care & Rapid Diagnostics Market

Figure 4: Global Point of Care & Rapid Diagnostics Market: Drivers

Figure 5: Global Point of Care & Rapid Diagnostics Market: Challenges

Figure 6: Global Point of Care & Rapid Diagnostics Market: Trends

Figure 7: Global Point of Care & Rapid Diagnostics Market: Opportunity

Figure 8: Global Point of Care & Rapid Diagnostics Market: Restraint

Figure 9: Global Point of Care & Rapid Diagnostics Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Point of Care & Rapid Diagnostics Market Value (USD Million) By Region

Figure 15: Global Point of Care & Rapid Diagnostics Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Point of Care & Rapid Diagnostics Market Value (USD Million) By Region

Figure 23: Global Point of Care & Rapid Diagnostics Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

91 items

Table 1: Market Segmentation Analysis

Table 2: Global Point of Care & Rapid Diagnostics Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Point of Care & Rapid Diagnostics Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Point of Care & Rapid Diagnostics Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Point of Care & Rapid Diagnostics Market Value (USD Million) By Region

Table 10: Global Point of Care & Rapid Diagnostics Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Point of Care & Rapid Diagnostics Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Point of Care & Rapid Diagnostics Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Point of Care & Rapid Diagnostics Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Johnson and Johnson Basic Information And Sales Area

Table 31: Johnson and Johnson. Products Portfolio

Table 32: Thermo Fisher Scientific Basic Information And Sales Area

Table 33: Thermo Fisher Scientific. Products Portfolio

Table 34: Bio-Techne Basic Information And Sales Area

Table 35: Bio-Techne. Products Portfolio

Table 36: Roche Diagnostics Basic Information And Sales Area

Table 37: Roche Diagnostics. Products Portfolio

Table 38: Siemens Healthineers Basic Information And Sales Area

Table 39: Siemens Healthineers. Products Portfolio

Table 40: Abbott Laboratories Basic Information And Sales Area

Table 41: Abbott Laboratories. Products Portfolio

Table 42: Danaher Corporation Basic Information And Sales Area

Table 43: Danaher Corporation. Products Portfolio

Table 44: BD Basic Information And Sales Area

Table 45: BD. Products Portfolio

Table 46: Sysmex Basic Information And Sales Area

Table 47: Sysmex. Products Portfolio

Table 48: Cardinal Health Basic Information And Sales Area

Table 49: Cardinal Health. Products Portfolio

Table 50: Quidel Basic Information And Sales Area

Table 51: Quidel. Products Portfolio

Table 52: GE Healthcare Basic Information And Sales Area

Table 53: GE Healthcare. Products Portfolio

Table 54: EKF Diagnostics Basic Information And Sales Area

Table 55: EKF Diagnostics. Products Portfolio

Table 56: bioMérieux SA Basic Information And Sales Area

Table 57: bioMérieux SA. Products Portfolio

Table 58: Accubiotech Basic Information And Sales Area

Table 59: Accubiotech. Products Portfolio

Table 60: PTS Diagnostics Basic Information And Sales Area

Table 61: PTS Diagnostics. Products Portfolio

Table 62: Chembio Diagnostics Basic Information And Sales Area

Table 63: Chembio Diagnostics. Products Portfolio

Table 64: Trinity Biotech Basic Information And Sales Area

Table 65: Trinity Biotech. Products Portfolio

Table 66: Sekisui Diagnostics Basic Information And Sales Area

Table 67: Sekisui Diagnostics. Products Portfolio

Table 68: Global Market Value (USD Million) (2025-2032) By Application

Table 69: Global Market Share (%) By Application (2032)

Table 70: Global Market Value (USD Million) (2025-2032) By Types

Table 71: Global Market Share (%) By Types (2032)

Table 72: Global Point of Care & Rapid Diagnostics Market Value (USD Million) By Region

Table 73: Global Point of Care & Rapid Diagnostics Market Share (%) By Region (2025-2032)

Table 74: North America Market Value (USD Million) (2025-2032) By Country

Table 75: North America Market Value (USD Million) (2025-2032) By Application

Table 76: North America Market Value (USD Million) (2025-2032) By Types

Table 77: Europe Market Value (USD Million) (2025-2032) By Country

Table 78: Europe Market Value (USD Million) (2025-2032) By Application

Table 79: Europe Market Value (USD Million) (2025-2032) By Types

Table 80: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 81: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 82: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 83: South America Market Value (USD Million) (2025-2032) By Country

Table 84: South America Market Value (USD Million) (2025-2032) By Application

Table 85: South America Market Value (USD Million) (2025-2032) By Types

Table 86: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 87: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 88: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 89: Research Programs/Design For This Report

Table 90: Key Data Information From Secondary Sources

Table 91: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Point of Care & Rapid Diagnostics Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	12.80 million
Revenue forecast in 2033	24.05 million
Growth rate	CAGR of 8.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Johnson and Johnson; Thermo Fisher Scientific; Bio-Techne; Roche Diagnostics; Siemens Healthineers; Abbott Laboratories; Danaher Corporation; BD; Sysmex; Cardinal Health; Quidel; GE Healthcare; EKF Diagnostics; bioMérieux SA; Accubiotech; PTS Diagnostics; Chembio Diagnostics; Trinity Biotech; Sekisui Diagnostics
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options